Comments: NJ S4601 | 2026-2027 | Regular Session

Bill Title: Requires pharmacist or pharmacist's designee to notify consumer of substituted drug or biological product.

Sponsorship: Partisan Bill (Democrat 3)

Status: (Engrossed) 2026-10-29 - Received in the Assembly, Referred to Assembly Health Committee [S4601 Detail]

Text: Latest bill text (Amended) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2026 New Jersey S4601 at this time.

feedback